ArticlePharmaceuticals (Basel, Switzerland)2022

Design, Synthesis and Biological Evaluation of Neogliptin, a Novel 2-Azabicyclo[2.2.1]heptane-Based Inhibitor of Dipeptidyl Peptidase-4 (DPP-4).

Ivan O Maslov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.